Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis

被引：23
|
作者：
Siegfried, Elaine C. [1 ,2 ]
Igelman, Sean [1 ]
Jaworsk, Jennifer C. [3 ]
Antaya, Richard J. [4 ]
Cordoro, Kelly M. [5 ]
Eichenfield, Lawrence F. [6 ,7 ]
Levy, Moise L. [8 ,9 ]
Paller, Amy S. [10 ,11 ]
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] Cardinal Glennon Childrens Hosp, St Louis, MO 63104 USA
[3] ApotheCom, Yardley, PA USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[6] Rady Childrens Hosp, San Diego, CA USA
[7] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[8] Univ Texas Austin, Dell Childrens Med Ctr Cent Texas, Austin, TX 78712 USA
[9] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA
[10] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[11] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
来源：
PEDIATRIC DERMATOLOGY | 2019年 / 36卷 / 01期
关键词：
adverse effects; atopic dermatitis; biologic; dupilumab; pediatric drug use; DUPILUMAB;
D O I：
10.1111/pde.13707
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：172 / 176
页数：5
相关论文
共 50 条
  • [31] Current and emerging biologics for the treatment of pediatric atopic dermatitis
    Ghamrawi, Rima
    Bell, Katheryn A.
    Balogh, Esther A.
    Strowd, Lindsay C.
    Feldman, Steven R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (12) : 1435 - 1445
  • [32] A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults
    Lynde, Charles W.
    Bourcier, Marc
    Gooderham, Melinda
    Guenther, Lyn
    Hong, Chih-ho
    Papp, Kim A.
    Poulin, Yves
    Sussman, Gordon
    Vender, Ronald
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2018, 22 (01) : 78 - 83
  • [33] Skin Barrier Dysfunction in Contact Dermatitis and Atopic Dermatitis-Treatment Implications
    Aviv, H.
    Herzinger, T.
    Molin, S.
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2020, 7 (03) : 390 - 402
  • [34] EASI 100 as a Therapeutic Target in Pediatric Atopic Dermatitis
    Teixeira, Joao
    Aparicio-Martins, Andre
    Pedroso, Mariana
    Figueiredo, Carolina
    Santiago, Felicidade
    Batista, Mariana
    Goncalo, Margarida
    Ramos, Leonor
    DERMATOLOGIC THERAPY, 2025, 2025 (01)
  • [35] Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Villegas, Susan C.
    Dima, Lorena
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (02) : E117 - E125
  • [36] Severe atopic dermatitis in childhood in the era of personalized medicine
    Ureta, Rosario Aguero
    Bravo, Edinson Lopez
    Zegpi, Maria Trinidad Hasbun
    ANDES PEDIATRICA, 2024, 95 (03): : 236 - 243
  • [37] Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis
    Kamal, Mohamed A.
    Kosloski, Matthew P.
    Lai, Ching-Ha
    Partridge, Michael A.
    Rajadhyaksha, Manoj
    Kanamaluru, Vanaja
    Bansal, Ashish
    Shabbir, Arsalan
    Shumel, Brad
    Ardeleanu, Marius
    Richards, Susan M.
    Yan, Hong
    Xu, Christine R.
    Rodriguez-Marco, Ainara
    Xiao, Jing
    Khokhar, Faisal A.
    Gherardi, Guy
    Babilonia, Elisa
    Maloney, Jennifer
    Mortensen, Eric
    Akinlade, Bolanle
    Braunstein, Ned
    Stahl, Neil
    Torri, Albert
    Davis, John D.
    Dicioccio, A. Thomas
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
    Rial Prado, Manuel Jorge
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2018, 28 (06) : 420 - 421
  • [39] An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
    Labib, Angelina
    Yosipovitch, Gil
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (11) : 1107 - 1118
  • [40] Atopic Dermatitis and Cytokines: Recent Patents in Immunoregulatory and Therapeutic Implications of Cytokines in Atopic Dermatitis - Part I: Cytokines in Atopic Dermatitis
    Lee, JaeHo
    Noh, Geunwoong
    Lee, Soojin
    Youn, YouSook
    Rhim, JungWoo
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2012, 6 (03) : 222 - 247
12345